Vaccinating to protect a vulnerable subpopulation

被引:58
作者
Dushoff, Jonathan [1 ]
Plotkin, Joshua B.
Viboud, Cecile
Simonsen, Lone
Miller, Mark
Loeb, Mark
Earn, David J. D.
机构
[1] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA
[2] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA
[3] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA
[4] NIAID, NIH, Bethesda, MD 20892 USA
[5] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
[6] McMaster Univ, Dept Math & Stat, Hamilton, ON, Canada
来源
PLOS MEDICINE | 2007年 / 4卷 / 05期
关键词
D O I
10.1371/journal.pmed.0040174
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Epidemic influenza causes serious mortality and morbidity in temperate countries each winter. Research suggests that schoolchildren are critical in the spread of influenza virus, while the elderly and the very young are most vulnerable to the disease. Under these conditions, it is unclear how best to focus prevention efforts in order to protect the population. Here we investigate the question of how to protect a population against a disease when one group is particularly effective at spreading disease and another group is more vulnerable to the effects of the disease. Methods and Findings We developed a simple mathematical model of an epidemic that includes assortative mixing between groups of hosts. We evaluate the impact of different vaccine allocation strategies across a wide range of parameter values. With this model we demonstrate that the optimal vaccination strategy is extremely sensitive to the assortativity of population mixing, as well as to the reproductive number of the disease in each group. Small differences in parameter values can change the best vaccination strategy from one focused on the most vulnerable individuals to one focused on the most transmissive individuals. Conclusions Given the limited amount of information about relevant parameters, we suggest that changes in vaccination strategy, while potentially promising, should be approached with caution. In particular, we find that, while switching vaccine to more active groups may protect vulnerable groups in many cases, switching too much vaccine, or switching vaccine under slightly different conditions, may lead to large increases in disease in the vulnerable group. This outcome is more likely when vaccine limitation is stringent, when mixing is highly structured, or when transmission levels are high.
引用
收藏
页码:921 / 927
页数:7
相关论文
共 31 条
[1]   A comparative analysis of influenza vaccination programs [J].
Bansal, Shweta ;
Pourbohloul, Babak ;
Meyers, Lauren Ancel .
PLOS MEDICINE, 2006, 3 (10) :1816-1825
[2]  
Bridges Carolyn B, 2003, MMWR Recomm Rep, V52, P1
[3]   Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system [J].
Brownstein, JS ;
Kleinman, KP ;
Mandl, KD .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 162 (07) :686-693
[4]   A GENERAL-SOLUTION OF THE PROBLEM OF MIXING OF SUBPOPULATIONS AND ITS APPLICATION TO RISK-STRUCTURED AND AGE-STRUCTURED EPIDEMIC MODELS FOR THE SPREAD OF AIDS [J].
BUSENBERG, S ;
CASTILLOCHAVEZ, C .
IMA JOURNAL OF MATHEMATICS APPLIED IN MEDICINE AND BIOLOGY, 1991, 8 (01) :1-29
[5]  
Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1183
[6]   Dynamical resonance can account for seasonality of influenza epidemics [J].
Dushoff, J ;
Plotkin, JB ;
Levin, SA ;
Earn, DJD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (48) :16915-16916
[7]   THE EFFECTS OF POPULATION HETEROGENEITY ON DISEASE INVASION [J].
DUSHOFF, J ;
LEVIN, S .
MATHEMATICAL BIOSCIENCES, 1995, 128 (1-2) :25-40
[8]   Pathogen-driven outbreaks in forest defoliators revisited: Building models from experimental data [J].
Dwyer, G ;
Dushoff, J ;
Elkinton, JS ;
Levin, SA .
AMERICAN NATURALIST, 2000, 156 (02) :105-120
[9]   Public health - Who should get influenza vaccine when not all can? [J].
Emanuel, EJ ;
Wertheimer, A .
SCIENCE, 2006, 312 (5775) :854-855
[10]   Influenza - Crisis underscores fragility of vaccine production system [J].
Enserink, M .
SCIENCE, 2004, 306 (5695) :385-385